MedImmune Offer Comes In High: AstraZeneca To Pay $15.2 Billion April 24, 2007 By Jim Shrine MedImmune Inc., which officially put itself up for sale less than two weeks ago, agreed Monday to be acquired by AstraZeneca plc for $15.2 billion. (BioWorld Today)Read More
RSS